DIAGNOS Inc. (CVE:ADK – Get Free Report) Director Robert Dunn acquired 105,000 shares of the firm’s stock in a transaction dated Friday, August 28th. The shares were acquired at an average price of C$0.48 per share, with a total value of C$50,400.00. Following the acquisition, the director owned 2,679,920 shares in the company, valued at approximately C$1,286,361.60. The trade was a 4.08% increase in their position.
Robert Dunn also recently made the following trade(s):
- On Wednesday, July 29th, Robert Dunn bought 200,000 shares of DIAGNOS stock. The shares were acquired at an average price of C$0.30 per share, for a total transaction of C$60,000.00.
DIAGNOS Stock Up 1.0%
CVE:ADK traded up C$0.01 during mid-day trading on Friday, hitting C$0.49. 312,857 shares of the company’s stock traded hands, compared to its average volume of 226,157. The company has a fifty day moving average of C$0.30 and a 200 day moving average of C$0.27. The company has a debt-to-equity ratio of 204.05, a quick ratio of 0.68 and a current ratio of 1.49. DIAGNOS Inc. has a twelve month low of C$0.17 and a twelve month high of C$0.52. The company has a market capitalization of C$59.60 million, a P/E ratio of -12.38 and a beta of -0.14.
DIAGNOS Company Profile
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.
Recommended Stories
- Five stocks we like better than DIAGNOS
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.
